Effects of carbamazepine treatment on pain threshold values and brain serotonin levels in rats

Pharmacology

Volumn 54, Issue 3, 1997, Pages 113-117

  Pinelli, Arnaldo ^a   Trivulzio, Silvio ^a   Tomasoni, Livio ^a  

^a Chemotherapy and Medical Toxicology ^*  (Italy)

Author keywords

Analgesia; Antiepileptic agents; Brain, rat; Plasma tryptophan; Serotonin

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; SEROTONIN; TRYPTOPHAN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; TRYPTOPHAN BRAIN LEVEL;

EID: 0030962024     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139477     Document Type: Article

References (23)

1. Rail TW. Schleifer LS: Drugs effective in the therapy of the epilepsies: in Goodman Gilnian A. Rail TW, Nies AS, Taylor P (eds): The Pharmacological Basis of Therapeutics, ed 8. New York, Pergamon Press, 1990. pp 436-462.
2. Tomson T, Tybring G. Berillson L. Ekbon K, Rane A: Carbamazepine therapy in trigeminal neuralgia. Clinical effects in relation to plasma concentration. Arch Neurol 1980: 37:699-703.
3. D'Alcssio DJ: Medical treatment of trigeminal neuralgia. Clin Neuro-surg 1976:24:579-585.
4. Pratt JA, Jenner P, Jhonson AL, Shoruon SD. Reynolds EH: Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: Implications for antiepileptic action and mental function. J Neurol Ncurosurg Psychiatry 1984: 47:1131-1133.
5. Young SN, Authier SG, Anderson GM, Purdy WC: Tryptophan, 5-hy-droxyindolacetic acid and indole acetic acid in human cerebrospinal fluid: Interrelationships and the influence of age. sex. epilepsy and anticonvulsant drugs. J Neurol Neuro-surg Psychiatry 1980:43:438-445.
6. Curzon G: Relationship between plasma. CSF and brain tryptophan. J Neural Transm Suppl 1979; 15:81-92.
7. Andersen E. Dafny N: An ascending serotoninergic pain modulation pathway from the dorsal raphe nucleus to the parafascicularis nucleus of the thalamus. Brain Res 1983: 269:57-67.
8. Lebars D. Dickenson AM, Rivot JP, Chaouch A, Krauss, K, Besson JM: Les systèmes sérotoninergiques bulbo-spinaux jouent-ils un role dans la detection des messages nociceptifs? J Physiol 1981;77:463-474.
9. Dewey WL. Harris LS. Howes JF. Kennedy JS. Pars H: Narcotics antagonists analgesics, possible cholinergic mechanism. J Pharmacol Exp Ther 1969;169:17-18.
10. Lackovic Z, Parenti M, Neff NH: Simultaneous determination of fen-tomole quantities of 5-hydroxytrvp-tophan serotonin and 5-hydroxy-indoleacetic acid in brain using HPLC with electrochemical detection. Eur J Pharmacol 1981:69:347-352.
11. Chelbcrg D. Gunawan D. Treiman N: Simultaneous high-performance liquid chromatographic determination of carbamazepine and its principal metabolites in human plasma and urine. Ther Drug Monit 1988: 10:188-193.
12. Lison I: Statistica applicata alia bio-logia spcrimentale. Milano. Editricc Ambrosiana. 1961. pp 96-102.
13. Yan QS. Mishra PK. Burger RL. Bultendorf AF, Jobe PC, Dailey JW: Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotoninergic neurons in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;261:652-659.
14. Dailey JW. Yan QS. Adam-Curtis LE. Ryu JR, Ko KH. Mishra PK. Jobe PC: Neurochemical correlation of antiepileptic drugs in the genetically epilepsy-prone rats (GEPR). LifeSei 1995;58:259-266.
15. Besson JM. Chaouch A: Descending serotoninergic systems; in Akil H. Lewis JW (eds): Neurotransmitters and Pain Control. Pain anc Headache. Basel. Karger, 1987. vol 9. pp 64-100.
16. Schmaus C. Hammond DL, Ochi JW. Yaksh TL: Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur J Pharmacol 1983:90: 349-357.
17. Chitour D. Dickenson AH. Lc Bars D: Pharmacological evidence for the involvement of serotoninergic mechanisms in diffuse noxious inhibitory controls (DN1C). Brain Res 1982:236:329-337.
18. Rivot JP. Chiang CY, Besson JM: Increase of serotonin metabolism within the dorsal horn of the spinal cord during nucleus raphe magnus stimulation, as revealed by in vivo electrochemical detection. Brain Res 1982:238:117-126.
19. Rang HP, Dale MM. Ritter JM: Pharmacology, ed 3. London, Churchill Livingstone, 1995. pp 609-633.
20. Giordano J: Analgesic profile of centrally administered 2-methylsero-tonin agonist acute pain in rats. Eur J Pharmacol 1991;199:233-236.
21. Eide PK. Hole K: The role of 5-hydroxytryptamine (5HT) receptors subtypes and plasticity in the 5HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993; 13:75-85.
22. Eide PK. Mjcllem N. Hole K: The role of spinal cord 5HTia and 5HTib receptors in the modulation of a spinal nociceptive reflex. Brain Res 1990:536:195-200.
23. Kajekar R, Gupta P. Shcppcrson NP. Brian SD: Effect of a 5HT, receptor agonist, CP-122,288 on oedema formation induced by stimulation of the rat saphenous nerve. Br J Pharmacol 1995;i 15:1-2.